pharma · Diabetic Macular Edema (DME)
Bio-Thera Solutions
Bio-Thera Solutions is a pharma organization headquartered in CN. Primary therapeutic focus areas include Diabetic Macular Edema (DME). NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s
Guangzhou, CN HQ
2003 Founded
31 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Guangzhou, CN
- Founded
- 2003
- Employees
- 31
- Programs
- 1
- Drugs
- 2
- Patents
- 0
BAT5906 injection
Phase 3 · small molecule · Diabetic Macular Edema (DME)
BAT5906 injection for Diabetic Macular Edema (DME) is a Phase 3 program (small_molecule) at Bio-Thera Solutions with 1 ClinicalTrials.gov record(s).
Internal code BAT5906-005-CR
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Bio-Thera Solutions
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Diabetic Macular Edema (DME)
- Status
- active
- Trials
- 1